Clin2
NCT03865290Possibly a fitRecruiting

Ondansetron for stomach nerve and motion problems in diabetes

IndigestionDiabetes Mellitus

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests whether ondansetron can improve stomach “sensorimotor” problems—how the gut senses food and moves it—especially in people with diabetes and troubling indigestion. It may help reduce symptoms like early fullness, nausea, and discomfort after eating.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be age 18–75 and able to sign consent before joining
  • You have symptoms of indigestion such as early fullness, nausea, vomiting, regurgitation, or post-meal discomfort
  • If you have diabetes: it must be type 1 or type 2 for at least 3 years, and for type 2 the symptoms should have started or worsened after diabetes was diagnosed
  • You must be able to communicate with the study team and eat the study meals as instructed
  • You should NOT be pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06941545Recruiting
Stomach mapping study for functional dyspepsia

This study uses a special stomach mapping technique and a tube to measure stomach activity in people with functional dyspepsia (long-term stomach discomfort or pain). The goal is to better understand how the stomach works, which could help improve future treatments.

Rochester, Minnesota
NCT06068114Recruiting
Stomach function study in people with diabetes

This study looks at how diabetes affects stomach function by measuring stomach activity with special tests. It may help doctors better understand and treat stomach problems in people with diabetes.

Ostrava
NCT06861010Recruiting· Phase 3
Ondansetron to prevent pancreatitis after ERCP

This trial tests whether ondansetron, a medicine that helps control nausea and vomiting, can reduce the risk of pancreatitis (inflammation of the pancreas) after an ERCP procedure. If you are scheduled for an ERCP and do not have certain health issues, you may be able to join.

Tanta
NCT07784127Not yet recruiting
How GLP-1 medicines affect stomach and bowel movement

This study will look at how medicines like Ozempic, Wegovy, and Mounjaro affect how well the stomach and intestines move food through the body. It might help find out why these medicines cause digestive problems for some people.

Cleveland, Ohio
NCT06340217Recruiting
Washed Microbiota Transplant for Diabetic Stomach Paralysis

This trial tests a new treatment called washed microbiota transplantation for diabetic gastroparesis, a condition where the stomach empties slowly due to diabetes. If you have had diabetes for over a year and struggle with bloating or feeling full quickly, this study may explore whether transplanting healthy gut bacteria can help relieve your symptoms.

Nanjing, Jiangsu
NCT06695962Not yet recruiting· Phase 3
Domperidone for type 1 diabetes with delayed stomach emptying

This trial tests whether a medicine called domperidone, which helps the stomach empty faster, can improve blood sugar control in people with type 1 diabetes who have slow stomach emptying. It may help by reducing blood sugar swings and early after-meal lows.

Amiens

Hear when a new Indigestion trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.